Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

cbdMD (YCBD) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for cbdMD (YCBD) over the last 10 years, with Q4 2025 value amounting to -$276942.0.

  • cbdMD's Change in Accured Expenses fell 1696.67% to -$276942.0 in Q4 2025 from the same period last year, while for Dec 2025 it was -$302055.0, marking a year-over-year increase of 7990.59%. This contributed to the annual value of -$261883.0 for FY2025, which is 7670.37% up from last year.
  • Per cbdMD's latest filing, its Change in Accured Expenses stood at -$276942.0 for Q4 2025, which was down 1696.67% from -$67251.0 recorded in Q3 2025.
  • Over the past 5 years, cbdMD's Change in Accured Expenses peaked at $763157.0 during Q2 2021, and registered a low of -$1.6 million during Q3 2024.
  • For the 5-year period, cbdMD's Change in Accured Expenses averaged around -$168466.0, with its median value being -$53808.0 (2025).
  • As far as peak fluctuations go, cbdMD's Change in Accured Expenses plummeted by 149492.94% in 2023, and later skyrocketed by 2057744.36% in 2025.
  • Over the past 5 years, cbdMD's Change in Accured Expenses (Quarter) stood at -$127254.0 in 2021, then surged by 130.81% to $39204.0 in 2022, then skyrocketed by 262.95% to $142292.0 in 2023, then crashed by 266.4% to -$236770.0 in 2024, then dropped by 16.97% to -$276942.0 in 2025.
  • Its Change in Accured Expenses was -$276942.0 in Q4 2025, compared to -$67251.0 in Q3 2025 and $82503.0 in Q2 2025.